34 research outputs found
Standard of Practice for the Endovascular Treatment of Thoracic Aortic Aneurysms and Type B Dissections
Thoracic endovascular aortic repair (TEVAR) represents a minimally invasive technique alternative to conventional open surgical reconstruction for the treatment of thoracic aortic pathologies. Rapid advances in endovascular technology and procedural breakthroughs have contributed to a dramatic transformation of the entire field of thoracic aortic surgery. TEVAR procedures can be challenging and, at times, extraordinarily difficult. They require seasoned endovascular experience and refined skills. Of all endovascular procedures, meticulous assessment of anatomy and preoperative procedure planning are absolutely paramount to produce optimal outcomes. These guidelines are intended for use in quality-improvement programs that assess the standard of care expected from all physicians who perform TEVAR procedures
Pulsed dye densitometry with two different sensor types for cardiac output measurement after cardiac surgery: a comparison with the thermodilution technique
Remote-Conditioning Ischemia Provides a Potential Approach to Mitigate Contrast Medium-Induced Reduction in Kidney Function: A Retrospective Observational Cohort Study
Ethanol Decreases Cytosolic-Free Calcium Ions in Vascular Smooth Muscle Cells As Assessed by Digital Image Analysis
Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Impact of catheter down-sizing and power injector use on the amount of contrast medium delivered
Evidence from mosaic analysis of the masculinizing gene her–1for cell interactions inC. eleganssex determination
Cardiac output and cardiac index measured with cardiovascular magnetic resonance in healthy subjects, elite athletes and patients with congestive heart failure
<p>Abstract</p> <p>Background</p> <p>Cardiovascular Magnetic Resonance (CMR) enables non-invasive quantification of cardiac output (CO) and thereby cardiac index (CI, CO indexed to body surface area). The aim of this study was to establish if CI decreases with age and compare the values to CI for athletes and for patients with congestive heart failure (CHF).</p> <p>Methods</p> <p>CI was measured in 144 healthy volunteers (39 ± 16 years, range 21–81 years, 68 females), in 60 athletes (29 ± 6 years, 30 females) and in 157 CHF patients with ejection fraction (EF) below 40% (60 ± 13 years, 33 females). CI was calculated using aortic flow by velocity-encoded CMR and is presented as mean ± SD. Flow was validated in vitro using a flow phantom and in 25 subjects with aorta and pulmonary flow measurements.</p> <p>Results</p> <p>There was a slight decrease of CI with age in healthy subjects (8 ml/min/m<sup>2</sup> per year, r<sup>2</sup> = 0.07, p = 0.001). CI in males (3.2 ± 0.5 l/min/m<sup>2</sup>) and females (3.1 ± 0.4 l/min/m<sup>2</sup>) did not differ (p = 0.64). The mean ± SD of CI in healthy subjects in the age range of 20–29 was 3.3 ± 0.4 l/min/m<sup>2</sup>, in 30–39 years 3.3 ± 0.5 l/min/m<sup>2</sup>, in 40–49 years 3.1 ± 0.5 l/min/m<sup>2</sup>, 50–59 years 3.0 ± 0.4 l/min/m<sup>2</sup> and >60 years 3.0 ± 0.4 l/min/m<sup>2</sup>. There was no difference in CI between athletes and age-controlled healthy subjects but HR was lower and indexed SV higher in athletes. CI in CHF patients (2.3 ± 0.6 l/min/m<sup>2</sup>) was lower compared to the healthy population (p < 0.001). There was a weak correlation between CI and EF in CHF patients (r<sup>2</sup> = 0.07, p < 0.001) but CI did not differ between patients with NYHA-classes I-II compared to III-IV (n = 97, p = 0.16) or patients with or without hospitalization in the previous year (n = 100, p = 0.72). In vitro phantom validation showed low bias (−0.8 ± 19.8 ml/s) and in vivo validation in 25 subjects also showed low bias (0.26 ± 0.61 l/min, QP/QS 1.04 ± 0.09) between pulmonary and aortic flow.</p> <p>Conclusions</p> <p>CI decreases in healthy subjects with age but does not differ between males and females. We found no difference in CI between athletes and healthy subjects at rest but CI was lower in patients with congestive heart failure. The presented values can be used as reference values for flow velocity mapping CMR.</p